1.
Agus Setyawan U, Purnamawati C, Pratiwi S. Progression Free Survival in Lung Cancer Adenocarcinoma Wild Type Patients with Pemetrexed Regimen Combination of Cisplatin compared to Carboplatin. JK-RISK [Internet]. 2025Feb.25 [cited 2025Jun.1];4(2):87-4. Available from: https://jk-risk.org/index.php/jk-risk/article/view/108